4:16 PM ET
8-K
Loan & Debt
Jazz Pharmaceuticals $1.9B Debt Financing with Bank of America, N.A.
Jazz Pharmaceuticals' subsidiary, Jazz Financing Lux S.à r.l., entered into a repricing amendment to its credit agreement to refinance $1.895 billion in outstanding term loans. The new Tranche B-3 Dollar Term Loans extend the maturity date from May 2028 to May 2033 and reduce the interest rate margin by 50 basis points to Term SOFR plus 1.75%.
- Value
- $1.9B
- Counterparty
- Bank of America, N.A.
- Term
- through May 2033